The Europe Cellular Health Screening Market would witness market growth of 8.7% CAGR during the forecast period (2022-2028).
Compound library screening for effects on living cells has evolved over the past ten years into a crucial and essential phase in almost every drug discovery effort. This strategy emerged from the awareness that biochemical assay-based screening campaigns, while incredibly productive, had fallen short of their promise to produce safer and more effective medications. The obvious benefit of screening utilizing cell-based assays is the ability to assess a compound's effects against molecular targets while it is still in a living cell.
However, screening also permits broad, systems biology techniques to study cellular pathways implicated in disease processes. In fact, cell-based diagnostic technologies have made it possible for researchers studying drug discovery to create models of interlinked cellular pathways, gather crucial data for particular disease models, and create companion diagnostics based on pertinent cellular biomarkers for treatments.
Cell-based screening automated systems are developing. The potential to screen substances against druggable targets in the regard of living cells has essentially become standard practice in both secondary and primary drug-screening programs, ranging from straightforward cell-based fluorescent, luminescent, colorimetric, and radiologic plate reader assays to real-time intracellular calcium feedback measurement techniques and high-content fluorescent imaging systems.
The EU recently introduced a novel strategy to assist Member States in boosting cancer screening uptake as a component of the EU Cancer Screening Scheme to be proposed under Europe's Beating Cancer Plan. The goal of the new guideline is to increase screenings, covering additional target groups and malignancies, with a focus on early cancer diagnosis. According to the European Commission, by 2025, 90% of EU citizens who are eligible for breast, cervical, and colorectal cancer examinations will be provided with such screenings owing to a new EU strategy that is based on the most recent scientific advancements and data. The revised guideline also includes lung, prostate, and, in some cases, stomach cancers in population-based organized cancer screening.
The Germany market dominated the Europe Cellular Health Screening Market by Country in 2021; thereby, achieving a market value of $278.2 million by 2028. The UK market would witness a CAGR of 7.8% during (2022 - 2028). Additionally, The France market is anticipated to grow a CAGR of 9.6% during (2022 - 2028).
Based on Sample Type, the market is segmented into Blood, Saliva, Serum, and Urine. Based on Collection Site, the market is segmented into Hospital, Diagnostic Labs, Home, and Office. Based on Test Type, the market is segmented into Single Test Panels and Multi-test Panels. Based on Single Test Panels Type, the market is segmented into Oxidative Stress Tests, Inflammation Tests, Telomere Tests, and Heavy Metals Tests. The report also covers geographical segmentation of Cellular Health Screening market. Based on countries, the market is segmented into Germany, UK, France, Russia, Spain, Italy, and Rest of Europe.
Free Valuable Insights: The Global Cellular Health Screening Market will Hit $4.3 Billion by 2028, at a CAGR of 9%
The market research report covers the analysis of key stake holders of the market. Key companies profiled in the report include Quest Diagnostics Incorporated, OPKO Health, Inc., Laboratory Corporation of America Holdings, Genova Diagnostics, Telomere Diagnostics, Inc., Life Length, S.L., Repeat Diagnostics, Inc., SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.), Cell Science Systems Corp. and Segterra, Inc.
Scope of the Study
Market Segments Covered in the Report:
By Sample Type
By Collection Site
- Hospital
- Diagnostic Labs
- Home
- Office
By Test Type
- Single Test Panels
- Oxidative Stress Tests
- Inflammation Tests
- Telomere Tests
- Heavy Metals Tests
- Multi-test Panels
By Country
- Germany
- UK
- France
- Russia
- Spain
- Italy
- Rest of Europe
Key Market Players
List of Companies Profiled in the Report:
Companies Profiled
- Quest Diagnostics Incorporated
- OPKO Health, Inc.
- Laboratory Corporation of America Holdings
- Genova Diagnostics
- Telomere Diagnostics, Inc.
- Life Length, S.L.
- Repeat Diagnostics, Inc.
- SpectraCell Laboratories, Inc. (Beingmate Group Co. Ltd.)
- Cell Science Systems Corp.
- Segterra, Inc.
TABLE 1 Europe Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 2 Europe Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 3 Europe Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 4 Europe Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 5 Europe Blood Market by Country, 2018 - 2021, USD Million
TABLE 6 Europe Blood Market by Country, 2022 - 2028, USD Million
TABLE 7 Europe Saliva Market by Country, 2018 - 2021, USD Million
TABLE 8 Europe Saliva Market by Country, 2022 - 2028, USD Million
TABLE 9 Europe Serum Market by Country, 2018 - 2021, USD Million
TABLE 10 Europe Serum Market by Country, 2022 - 2028, USD Million
TABLE 11 Europe Urine Market by Country, 2018 - 2021, USD Million
TABLE 12 Europe Urine Market by Country, 2022 - 2028, USD Million
TABLE 13 Europe Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 14 Europe Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 15 Europe Hospital Market by Country, 2018 - 2021, USD Million
TABLE 16 Europe Hospital Market by Country, 2022 - 2028, USD Million
TABLE 17 Europe Diagnostic Labs Market by Country, 2018 - 2021, USD Million
TABLE 18 Europe Diagnostic Labs Market by Country, 2022 - 2028, USD Million
TABLE 19 Europe Home Market by Country, 2018 - 2021, USD Million
TABLE 20 Europe Home Market by Country, 2022 - 2028, USD Million
TABLE 21 Europe Office Market by Country, 2018 - 2021, USD Million
TABLE 22 Europe Office Market by Country, 2022 - 2028, USD Million
TABLE 23 Europe Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 24 Europe Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 25 Europe Single Test Panels Market by Country, 2018 - 2021, USD Million
TABLE 26 Europe Single Test Panels Market by Country, 2022 - 2028, USD Million
TABLE 27 Europe Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 28 Europe Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 29 Europe Oxidative Stress Tests Market by Country, 2018 - 2021, USD Million
TABLE 30 Europe Oxidative Stress Tests Market by Country, 2022 - 2028, USD Million
TABLE 31 Europe Inflammation Tests Market by Country, 2018 - 2021, USD Million
TABLE 32 Europe Inflammation Tests Market by Country, 2022 - 2028, USD Million
TABLE 33 Europe Telomere Tests Market by Country, 2018 - 2021, USD Million
TABLE 34 Europe Telomere Tests Market by Country, 2022 - 2028, USD Million
TABLE 35 Europe Heavy Metals Tests Market by Country, 2018 - 2021, USD Million
TABLE 36 Europe Heavy Metals Tests Market by Country, 2022 - 2028, USD Million
TABLE 37 Europe Multi-test Panels Market by Country, 2018 - 2021, USD Million
TABLE 38 Europe Multi-test Panels Market by Country, 2022 - 2028, USD Million
TABLE 39 Europe Cellular Health Screening Market by Country, 2018 - 2021, USD Million
TABLE 40 Europe Cellular Health Screening Market by Country, 2022 - 2028, USD Million
TABLE 41 Germany Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 42 Germany Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 43 Germany Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 44 Germany Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 45 Germany Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 46 Germany Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 47 Germany Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 48 Germany Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 49 Germany Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 50 Germany Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 51 UK Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 52 UK Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 53 UK Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 54 UK Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 55 UK Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 56 UK Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 57 UK Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 58 UK Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 59 UK Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 60 UK Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 61 France Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 62 France Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 63 France Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 64 France Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 65 France Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 66 France Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 67 France Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 68 France Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 69 France Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 70 France Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 71 Russia Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 72 Russia Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 73 Russia Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 74 Russia Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 75 Russia Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 76 Russia Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 77 Russia Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 78 Russia Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 79 Russia Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 80 Russia Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 81 Spain Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 82 Spain Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 83 Spain Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 84 Spain Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 85 Spain Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 86 Spain Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 87 Spain Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 88 Spain Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 89 Spain Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 90 Spain Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 91 Italy Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 92 Italy Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 93 Italy Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 94 Italy Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 95 Italy Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 96 Italy Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 97 Italy Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 98 Italy Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 99 Italy Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 100 Italy Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 101 Rest of Europe Cellular Health Screening Market, 2018 - 2021, USD Million
TABLE 102 Rest of Europe Cellular Health Screening Market, 2022 - 2028, USD Million
TABLE 103 Rest of Europe Cellular Health Screening Market by Sample Type, 2018 - 2021, USD Million
TABLE 104 Rest of Europe Cellular Health Screening Market by Sample Type, 2022 - 2028, USD Million
TABLE 105 Rest of Europe Cellular Health Screening Market by Collection Site, 2018 - 2021, USD Million
TABLE 106 Rest of Europe Cellular Health Screening Market by Collection Site, 2022 - 2028, USD Million
TABLE 107 Rest of Europe Cellular Health Screening Market by Test Type, 2018 - 2021, USD Million
TABLE 108 Rest of Europe Cellular Health Screening Market by Test Type, 2022 - 2028, USD Million
TABLE 109 Rest of Europe Cellular Health Screening Market by Single Test Panels Type, 2018 - 2021, USD Million
TABLE 110 Rest of Europe Cellular Health Screening Market by Single Test Panels Type, 2022 - 2028, USD Million
TABLE 111 Key information – Quest Diagnostics Incorporated
TABLE 112 Key Information – OPKO Health, Inc.
TABLE 113 Key Information – Laboratory Corporation of America holdings
TABLE 114 Key Information – Genova Diagnostics
TABLE 115 Key Information – Telomere Diagnostics, Inc.
TABLE 116 Key Information – LIFE LENGTH, S.L.
TABLE 117 Key Information – Repeat Diagnostics, Inc.
TABLE 118 Key Information – SpectraCell Laboratories, Inc.
TABLE 119 Key Information – Cell Science Systems Corp.
TABLE 120 Key Information – SEGTERRA (INSIDETRACKER)
List of Figures
FIG 1 Methodology for the research
FIG 2 Recent strategies and developments: Quest Diagnostics Incorporated